文献速递急性肾损伤

胰岛素样生长因子结合蛋白7通过减轻多ADP核糖聚合酶1降解促进急性肾损伤

Insulin-like growth factor binding protein 7 promotes acute kidney injury by alleviating poly ADP ribose polymerase 1 degradation.
PubMed 文献 · Kidney Int · 2022-06-23

该研究发现IGFBP7在急性肾损伤患者和小鼠血液及尿液中高表达,可能通过c-Jun依赖机制上调,且与肾功能障碍正相关。IGFBP7主要来源于肾小管上皮细胞,通过结合PARP1并拮抗E3泛素连接酶RNF4抑制其降解,从而促进肾小管损伤和炎症。

要点

  • IGFBP7在急性肾损伤患者和小鼠血液及尿液中高表达,与肾功能障碍正相关
  • IGFBP7主要来源于肾小管上皮细胞,其敲除可减轻肾脏损伤和炎症
  • IGFBP7通过结合PARP1并拮抗RNF4抑制PARP1降解,促进肾小管损伤

核心结论

  • 循环中的IGFBP7作为急性肾损伤的生物标志物和关键介质,通过抑制RNF4/PARP1介导的肾小管损伤和炎症发挥作用。
  • IGFBP7/PARP1轴的过度激活是急性肾损伤治疗的一个有前景的靶点。

研究设计与样本

  • 研究检测了急性肾损伤患者和小鼠血液及尿液中IGFBP7的表达,并在顺铂、肾脏缺血/再灌注和脂多糖诱导的小鼠急性肾损伤模型中进行了全局敲除、条件性敲除和回补实验。
  • 体外实验使用重组IGFBP7蛋白、IGFBP7敲低或过表达来确定其功能。

主要发现

  • IGFBP7在急性肾损伤患者和小鼠的血液和尿液中高表达,可能通过c-Jun依赖机制上调,且与肾功能障碍正相关。
  • 全局敲除IGFBP7可改善顺铂、肾脏缺血/再灌注和脂多糖诱导的小鼠急性肾损伤模型中的肾功能障碍、炎症反应和程序性细胞死亡。
  • IGFBP7主要来源于肾脏肾小管上皮细胞,条件性敲除肾脏IGFBP7可防止急性肾损伤。
  • 在IGFBP7敲除小鼠中回补IGFBP7表达可恢复肾脏损伤和炎症。
  • IGFBP7结合PARP1并通过拮抗E3泛素连接酶RNF4抑制其降解。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The novel biomarker, insulin-like growth factor binding protein 7 (IGFBP7), is used clinically to predict different types of acute kidney injury (AKI) and has drawn significant attention as a urinary biomarker. However, as a secreted protein in the circulation of patients with AKI, it is unclear whether IGFBP7 acts as a key regulator in AKI progression, and if mechanisms underlying its upregulation still need to be determined. Here we found that IGFBP7 is highly expressed in the blood and urine of patients and mice with AKI, possibly via a c-Jun-dependent mechanism, and is positively correlated with kidney dysfunction. Global knockout of IGFBP7 ameliorated kidney dysfunction, inflammatory responses, and programmed cell death in murine models of cisplatin-, kidney ischemia/reperfusion-, and lipopolysaccharide-induced AKI. IGFBP7 mainly originated from kidney tubular epithelial cells. Conditional knockout of IGFBP7 from the kidney protected against AKI. By contrast, rescue of IGFBP7 expression in IGFBP7-knockout mice restored kidney damage and inflammation. IGFBP7 function was determined in vitro using recombinant IGFBP7 protein, IGFBP7 knockdown, or overexpression. Additionally, IGFBP7 was found to bind to poly [ADP-ribose] polymerase 1 (PARP1) and inhibit its degradation by antagonizing the E3 ubiquitin ligase ring finger protein 4 (RNF4). Thus, IGFBP7 in circulation acts as a biomarker and key mediator of AKI by inhibiting RNF4/PARP1-mediated tubular injury and inflammation. Hence, over-activation of the IGFBP7/PARP1 axis represents a promising target for AKI treatment.

来源:Kidney Int,查看原文。版权归原作者所有。

引用

  1. Yu JT, Hu XW, Yang Q, et al. Insulin-like growth factor binding protein 7 promotes acute kidney injury by alleviating poly ADP ribose polymerase 1 degradation. Kidney Int. 2022. PMID: 35752325. doi:10.1016/j.kint.2022.05.026

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。